Keyphrases
Cancer Stem Cells
100%
Pathway Inhibitors
100%
Insulinoma
100%
Notch Pathway
100%
Chemoresistant
100%
5-fluorouracil (5-FU)
55%
Stem Cells
44%
Malignant Insulinoma
22%
Notch Signaling
22%
Notch2
22%
γ-secretase Inhibitor
22%
Novel Targeted Therapy
22%
Hes1
22%
Chemotherapy
11%
Molecular Processes
11%
Tumor
11%
Stem Cell Population
11%
Sex-determining Region Y-box 2 (SOX2)
11%
Success Rate
11%
Octamer-binding Transcription Factor 4 (OCT4)
11%
Current Treatment
11%
Future Therapeutics
11%
Protein Analysis
11%
CD133
11%
CD34
11%
Combined Strategy
11%
Chemoresistance
11%
Clonogenicity
11%
Stem Cell Markers
11%
Engraftment
11%
Insulinoma Cells
11%
Non-cancer
11%
Long-term Prognosis
11%
Tumourigenicity
11%
Neuroendocrine Pancreatic Tumor
11%
Treatment Modalities
11%
SRY-box Transcription Factor 9 (SOX9)
11%
Medicine and Dentistry
Cancer Stem Cell
100%
Nesidioblastosis
100%
Notch
100%
Fluorouracil
45%
Targeted Therapy
18%
Gamma Secretase Inhibitor
18%
Notch Signaling
18%
In Vitro
9%
Cell Population
9%
Stem Cell
9%
Neoplasm
9%
Cell Marker
9%
Carcinogenicity
9%
Protein Analysis
9%
Engraftment
9%
Insulinoma Cell Line
9%
Pancreas Islet Cell Tumor
9%
Drug Resistance
9%
Biochemistry, Genetics and Molecular Biology
Notch
100%
Cancer Stem Cell
100%
Fluorouracil
55%
Notch Signaling Pathway
22%
Gamma Secretase
22%
HES1
22%
Protein Characterization
11%
Stem Cell Marker
11%
SOX2
11%
CD133
11%
Clonogenesis
11%
CD34
11%
SOX9
11%
Drug Resistance
11%
Pharmacology, Toxicology and Pharmaceutical Science
Insulinoma
100%
Malignant Neoplasm
100%
Fluorouracil
41%
Gamma Secretase Inhibitor
16%
Chemotherapy
8%
Protein Characterization
8%
Cell Marker
8%
Carcinogenicity
8%
Pancreas Islet Cell Tumor
8%
Neoplasm
8%
Drug Resistance
8%
Veterinary Science and Veterinary Medicine
Stem Cell
100%
Cancer
100%
HES1
22%
Dog
11%
Canine
11%
SOX2
11%
SOX9
11%
Stem Cell Marker
11%
Pancreatic Tumor
11%
Neoplasm
11%